GL1X · GenesisL1 explorer

Research workbench

Crystal structure of ERK2 complexed with allosteric and ATP- competitive inhibitors.

Analyse Crystal structure of ERK2 complexed with allosteric and ATP- competitive… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5AX3
Type
protein
Length
341 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mitogen-activated protein kinase 1; Allosteric and ATP-competitive inhibitor
EC
2.7.11.24
UniProt
P28482
Ligands
5ID
Pockets
4 · best druggability 0.68

Structure

x-ray diffraction · 2 distinct chains · 30% helix, 14% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMitogen-activated protein kinase 1 (EC 2.7.11.24)protein32932% helix, 15% strandP28482
BAllosteric and ATP-competitive inhibitorprotein120% helix, 0% strand—

Ligands and binding sites

  • 5ID · (2R,3R,4S,5R)-2-(4-amino-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)tetrahydrofuran-3, 4-diol · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13520.680.81395ID
2980.570.8622empty
31520.530.8023empty
4840.330.7414empty

Interfaces

1 interface between chains.

  • A–B · 610 Ų buried · 5 hydrogen bonds · protein-protein

Compared structures

  • 5AX3 · Crystal structure of ERK2 complexed with allosteric and ATP-competitive inhibitors. · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.